peptide calcium-sensing receptor agonistTherapeutic Peptides
Etelcalcetide (Parsabiv)
A synthetic peptide that activates the calcium-sensing receptor to reduce parathyroid hormone secretion. FDA-approved for secondary hyperparathyroidism in dialysis patients. First IV calcimimetic, administered during hemodialysis.
hyperparathyroidismdialysiscalcium-sensing-receptorPTH-suppressionFDA-approved
3D Structure
3D Structure
1048.29 Da
Lab Tested
No
Harmful Ingredients
0
Contaminants
None
Tested Purity
--
Batch Consistency
No batch data
Mass Spec Profile
ESI-MS (computed)
Batch Info
Latest Batch—
Total Tests0
Unique Vendors0
Vendor Comparison
No vendor data yet
Analysis Summary
Purity Standard
No purity dataLab Reports
0 reports on file
Summary
A synthetic peptide that activates the calcium-sensing receptor to reduce parathyroid hormone secretion. FDA-approved for secondary hyperparathyroidism in dialysis patients. First IV calcimimetic, adm…